109056 ⎘
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
Bio-Ink and Its Preparation and Application
#2CIRCULAR RNAS FOR CELLULAR THERAPY
#3System and Method for Identifying the Presence of Insects
#4High Throughput Cell-Based Screening For Aptamers
#5COMPOSITIONS AND METHODS FOR THE SYNTHESIS AND IDENTIFICATION OF COVALENT APTAMERS
#6HIGH-AFFINITY NUCLEIC ACID APTAMER FOR HISTAMINE AND AQUATIC PRODUCT FRESHNESS ENZYME SENSOR
#7MULTIVALENT TRIDENT APTAMERS FOR MOLECULAR RECOGNITION, METHODS OF MAKING AND USES THEREOF
#8COMPOSITIONS AND METHODS FOR THE TREATMENT OF COMPLICATIONS AND DISORDERS RELATING TO VON WILLEBRAND FACTOR
#9METHOD FOR TREATING SEPSIS AND RELATED DISEASES
#10G-QUADRUPLEX-CONTAINING OLIGONUCLEOTIDES
#11ANTIBODIES AND ENONOMERS
#12SINGLE-STRANDED DNA MOLECULAR RECOGNITION ELEMENTS AGAINST CYANOTOXIN L-BMAA
#13Method for Screening and Rationally Engineering Riboswitch Capable of Specifically Recognizing Doxycycline
#14TREATMENT FOR OVARIAN CANCER WITH OLIGONUCLEOTIDES TARGETING FIBROBLAST ACTIVATION PROTEIN ALPHA
#15DEGRADATION TARGETING AGENTS AND USES THEREOF
#16USE OF MODIFIED PHAGE FOR CAPTURING AND SUBTYPING OF CANCER CELLS
#17CLICK CHEMISTRY LIGAND
#18METHODS AND COMPOSITIONS OF APTAMERS FOR DETECTION OF LOW COMPLEXITY MOLECULES
#19PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS
#20COMPOSITIONS AND METHODS INVOLVING APTAMER SWITCH POLYNUCLEOTIDES
#21SYSTEMS AND METHODS FOR TARGETING NAD-BASED PATHWAYS FOR TREATMENT OF CANCER
#22INHIBITORS OF SARM1 IN COMBINATION WITH NAD+ OR A NAD+ PRECURSOR
#23DNA APTAMERS THAT BIND TO ALGINATE GELS
#24COMPOSITIONS AND METHODS FOR IMPROVED PROTEIN TRANSLATION FROM RECOMBINANT CIRCULAR RNAS
#25METHODS FOR PREPARING APTAMERS FOR SMALL MOLECULES
#26COMPOSITIONS AND METHODS RELATED TO NUCLEIC ACID SENSORS
#27CHEMICAL SENSORS EMPLOYING pH-SENSITIVE APTAMERS
#28COMPOSITIONS AND METHODS FOR TREATING PANCREATIC CANCER
#29MULTIPLEXABLE APTAMER-BASED LIGAND DETECTION
#30REGULATION OF GENE EXPRESSION BY APTAMER-MEDIATED MODULATION OF ALTERNATIVE SPLICING
#31METAL HOMEOSTASIS REGULATION
#32MULTISPECIFIC POLYNUCLEOTIDE NANOSTRUCTURES FOR CANCER DETECTION AND THERAPY
#33RNA-DNA FUSOMERS AND METHODS OF USE THEREOF
#34METHOD FOR SCREENING RNA APTAMER
#35BUILDING DESIGNER RNA NANO-STRUCTURES FOR SYNTHETIC BIOLOGY APPLICATIONS
#36THERMOSTABLE POLYMERASE INHIBITOR COMPOSITIONS AND METHODS
#37SPATIAL MRNA/PROTEIN CO-ASSAYS USING APTAMERS
#38SHIELDED SMALL NUCLEOTIDES FOR INTRACELLULAR BARCODING
#39RNA-GUIDED GENOME RECOMBINEERING AT KILOBASE SCALE
#40Epitope-Specific hCG Binding Aptamers and Applications Thereof
#41FLUOROGENIC NUCLEOSIDES
#42COMPOUNDS AND METHODS FOR REDUCING GLYCOGEN SYNTHASE 1
#43DNA APTAMERS AS UNIVERSAL INHIBITORS OF SPIKE PROTEIN/HACE2 INTERACTIONS
#44APTAMER-BASED MINERAL AND METAL COLLECTION
#45METHODS AND COMPOSITIONS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
#46DNA-CHIMERIC ANTIGEN RECEPTOR T CELLS FOR IMMUNOTHERAPY
#47PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING GLIOBLASTOMAS
#48New C5a Binding Nucleic Acids
#49TDP-43-BINDING SINGLE-STRANDED APTAMERS AND USES THEREOF
#50APTAMER, CONJUGATE, COMPOSITION, METHOD FOR PREPARING SAME, AND USE THEREOF
#51APPLICATION OF ZINC FINGER PROTEIN 217 GENE IN PREPARING MEDICINES FOR TREATING OSTEOPOROSIS
#52ULTRASENSITIVE AND MULTIPLEXED CELL-FREE BIOSENSORS USING CASCADED AMPLIFICATION AND POSITIVE FEEDBACK
#53SUPPRESSION OF TARGETED APTAMER CLUSTER
#54APTAMER-BASED POLLUTANT PROTECTION
#55FUNCTIONALIZED NUCLEIC ACID CONDENSATES AND RELATED CONDENSATE MONOMERS, LAYERED STRUCTURES, COMPOSITIONS METHODS AND SYSTEMS FOR SEPARATION, PURIFICATION, AND/OR DETECTION OF A BIOMOLECULAR TARGET
#56APTAMER AND RIBOZYME EQUILIBRIUM SHIFTING (ARES) RNA CIRCUITS AND USES THEREOF
#57HIGH-AFFINITY THROMBIN APTAMERS AND METHODS OF USE
#58COMPOUNDS FOR INHIBITING THE INTERACTION OF SARS-COV2 WITH HUMAN PROTEIN ACE2
#59DNA APTAMERS FOR INHIBITING REVERSE TRANSCRIPTASES
#60TETRAHEDRAL FRAMEWORK NUCLEIC ACID MODIFIED BY APTAMER AND TRANSFORMING GROWTH FACTOR beta 3, AND PREPARATION METHOD THEREOF
#61DNA Aptamers for Detection of L-Lactate and Methods Therefor
#62RNA APTAMER TARGETING OF ADAM8 IN CANCER GROWTH AND METASTASIS
#63NUCLEIC ACID APTAMER TEST STRIP, PREPARATION METHOD THEREFOR, AND USE THEREOF
#64NUCLEIC ACID STRUCTURE
#65Biradial Spherical Nucleic Acids
#66Modified Nucleosides
#67GPC3 APTAMERS AND VARIANTS AND USE THEREOF
#68DNA DISPLAY OF FOLDED RNA LIBRARIES ENABLING RNA-SELEX WITHOUT REVERSE TRANSCRIPTION
#69METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR APTAMER SELECTION
#70NUCLEIC ACID SEQUENCES RESPONSIVE TO CREATININE IN CLINICALLY USEFUL RANGES
#71DUAL-SPECIFICITY RNA ATPAMERS FOR REGULATING O-GLCNACYLATION
#72CONJUGATE, PHARMACEUTICAL COMPOSITION COMPRISING SAME, METHOD FOR PREPARING SAME, AND USE THEREOF
#73AFFINITY REAGENT, MARKER AND METHOD FOR ANALYSING A BIOLOGICAL SAMPLE
#74NUCLEIC ACID APTAMER, COMPOSITION, USE OF APTAMER, DIAGNOSTIC KIT, METHOD FOR DETECTING OR DIAGNOSING TUMOURS AND CANCER TREATMENT METHOD
#75MATRIX BOUND NANOVESICLES AND THEIR USE
#76APTAMER-BASED ELECTROCHEMICAL DRUG DETECTION ASSAY
#77Anti-Fibrinogen Aptamers
#78APTAMER BASED AFFINITY CAPTURE METHODS FOR THE SELECTIVE ENRICHMENT OF HUMAN IMMUNOGLOBULIN FC DOMAINS
#79NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PANCREATIC CANCER AND OTHER CANCERS
#80USE OF APTAMERS IN PROTEOMICS
#81METHODS AND COMPOSITIONS FOR THE MAKING AND USING OF GUIDE NUCLEIC ACIDS
#82Process to Inhibit or Eliminate Eosinophilic Diseases of the Airway and Related Conditions
#83METHODS FOR DETECTING AND TREATING CEREBRAL CAVERNOUS MALFORMATION
#84INSULIN RECEPTOR-BINDING APTAMER DIMER AND USE THEREOF
#85COMPOSITIONS AND METHODS FOR CIRCULAR RNA AFFINITY PURIFICATION
#86HYBRID CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF
#87PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST HEAD AND NECK SQUAMOUS CELL CARCINOMA AND OTHER CANCERS
#88ANALYTES' DETECTION USING REGULATED IN VITRO TRANSCRIPTION
#89TARGETED CELL SELECTION AND RELEASE USING APTAMER COMPLEXES IN A CELL PROCESSING SYSTEM
#90SENSOR DEVICE FOR SENSING A PRESENCE OF AN ANALYTE IN A BIOLOGICAL MATERIAL
#91RESPIRATORY TRACT INFECTION THERAPEUTICS AGAINST COVID-19
#92ANTI-C5 AGENT FOR TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION (AMD) OR GEOGRAPHIC ATROPHY SECONDARY TO DRY AMD
#93COMPOSITIONS AND METHODS FOR INHIBITING FACTOR D
#94INHIBITION OF DNA POLYMERASES BY URACIL-DNA GLYCOSYLASE-CLEAVABLE OLIGONUCLEOTIDE LIGANDS
#95METHODS OF TREATING CANCER AND MONITORING CANCER PROGRESSION
#96Materials & Methods for Treatment of Macular Degeneration
#97APTAMERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR PREVENTING OR TREATING BCMA-ASSOCIATED DISEASES OR CONDITIONS
#98PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST RENAL CELL CARCINOMA (RCC) AND OTHER CANCERS
#99Aptamers for Cortisol and Other Hormone Sensing, Aptamer-Based Sensors, and a Method for Optimizing Conformation-Switching Aptamers for Biosensing Applications
#100TRANS-SPLICING RNA (TSRNA)
#101UTERINE CANCER TREATMENTS
#102NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST BREAST CANCER AND OTHER CANCERS
#103METHODS, COMPOSITIONS, AND DEVICES INVOLVING PSEUDOKNOT FORMATION
#104COMPOSITIONS FOR SEQUESTERING ISOAMYL AMINE AND METHODS OF USE THEREFOR
#105Electrochemical Aptamer Sensors with Strong Sensor Response to Large Analytes
#106Oligonucleotides Comprising Modified Nucleosides
#107COMPOSITIONS AND METHODS FOR TREATING CANCERS
#108Bifunctional Molecules and Methods of Using Thereof
#109A METHOD FOR REPRODUCIBLE APTAMER SELECTION USING CLOSED SEQUENCE SOLUTION SPACES
#110A METHOD FOR REPRODUCIBLE APTAMER SELECTION USED TO IDENTIFY APTAMERS THAT BIND TO UNKNOWN BIOMARKERS
#111COMPOSITIONS AND METHODS RELATED TO APTAMER-BASED COLORIMETRIC ASSAYS
#112APTAMERS SPECIFIC TO EBV-ASSOCIATED MALIGNANCIES AND THEIR APPLICATIONS IN CANCER IMAGING AND THERAPIES
#113METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS
#114APTAMERS FOR DETECTING VARIANTS OF A TARGET ANALYTE, METHODS OF MAKING AND USES THEREOF
#115APTAMERS AND SMALL MOLECULE LIGANDS
#116COMPOSITIONS AND METHODS TO TREAT CANCER
#117Interferon Production Using Short RNA Duplexes
#118NUCLEIC ACID PROBE, CHEMICAL SENSOR, AND DETECTION METHOD
#119Aptamer-Based Fluorescence Polarization Detection Method for Extracellular Vesicles and Its Application
#120FUNCTIONALLY-ENHANCED XNA
#121ANTIGENIC PEPTIDES DERIVING FROM UROCORTIN 3 AND USES THEREOF FOR THE DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES
#122WEARABLE APTAMER FIELD-EFFECT TRANSISTOR SENSING SYSTEM FOR NONINVASIVE CORTISOL MONITORING AND WEARABLE SYSTEM FOR STRESS SENSING
#123PHARMACEUTICAL COMPOSITION FOR TREATING PERIPHERAL NERVE INJURY
#124NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST SMALL CELL LUNG CANCER AND OTHER CANCERS
#125EXOGENOUS CONTROL OF MAMMALIAN GENE EXPRESSION THROUGH APTAMER-MEDIATED MODULATION OF POLYADENYLATION
#126Aptamer Inactivation of Nucleases in Biological Solutions, Reagents, and Kits Used for Sample Collection, Nucleic Acid Testing, Isolation, and Genomic Characterization
#127PEPTIDES AND T CELLS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS
#128BOTTLEBRUSH CONJUGATES FOR USE AS OLIGONUCLEOTIDE ENHANCERS
#129RNA SEQUENCES THAT INDUCE FLUORESCENCE OF SMALL MOLECULE FLUOROPHORES, MOLECULAR COMPLEXES, SENSORS, AND METHODS OF USE THEREOF
#130RNA-GUIDED GENOME RECOMBINEERING AT KILOBASE SCALE
#131MIRROR-IMAGE SELECTION OF L-NUCLEIC ACID APTAMERS
#132A4B1 BINDING APTAMERS
#133BLOCK COPOLYMERS AND USES THEREOF
#134METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL CONDITIONS
#135ENGINEERED GYRI-LIKE MUTEIN APTAMERS, AND RELATED METHODS
#136NUCLEIC ACID-BASED ASSEMBLY AND USES THEREOF
#137PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS
#138COMPOSITIONS AND METHODS FOR TREATMENT OF BLEEDING DISORDERS
#139METHOD FOR ANALYSING A BIOLOGICAL SAMPLE
#140METHODS OF CELL CULTURE FOR ADOPTIVE CELL THERAPY
#141PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS
#142Aptamer for DKK1 and Use Thereof
#143HEAVY METAL TOXICITY REMEDIATION
#144METHODS FOR PROMOTING T CELLS RESPONSE
#145COMPOSITIONS AND METHODS FOR GENERATING SYNTHETIC LETHALITY IN TUMORS
#146RNA TARGETING OF MUTATIONS VIA SUPPRESSOR tRNAs AND DEAMINASES
#147METHOD FOR DETECTING AND QUANTIFYING RNA
#148MATERIALS AND METHODS FOR CONTROLLING GENE EXPRESSION
#149C5a binding nucleic acids
#150TREATMENT OF ELEVATED METABOLITE LEVELS USING NANOCARRIERS
#151APTAMERS FOR TARGETED ACTIVATION OF T CELL-MEDIATED IMMUNITY
#152PH-RESPONSIVE LIPID DERIVATIVE
#153CLICK HANDLE-MODIFIED DEOXY-FLUOROARABINO NUCLEIC ACID AS A SYNTHETIC GENETIC POLYMER CAPABLE OF POST-POLYMERIZATION FUNCTIONALIZATION
#154TARGETED AND SLOW-RELEASE DRUG CONJUGATE COMPOSITION
#155Compositions and methods for detecting SARS-CoV-2 spike protein
#156CHIMERIC COMPLEX AND THERAPEUTIC USES THEREOF
#157APTAMER-siRNA FUSIONS
#158RNA TARGETING OF MUTATIONS VIA SUPPRESSOR tRNAs AND DEAMINASES
#159NOVEL PEPTIDES & COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML & OTHER CANCERS
#160METHODS FOR TREATING SICKLE CELL DISEASE OR BETA THALASSEMIA USING A COMPLEMENT ALTERNATIVE PATHWAY INHIBITOR
#161PHARMACEUTICAL COMPOSITION FOR TREATING TRIPLE NEGATIVE BREAST CANCER, CONTAINING NON-NATURAL NUCLEIC ACID LIGAND AS ACTIVE INGREDIENT
#162Riboswitch modulated gene therapy for retinal diseases
#163PRODUCTS AND METHODS FOR PROMOTING MYOGENESIS
#164NON-NATURAL NUCLEIC ACID LIGAND, USES THEREOF, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT
#165COMPOSITIONS AND METHODS FOR RNA AFFINITY
#166VON WILLEBRAND FACTOR (VWF)-TARGETING AGENTS AND METHODS OF USING THE SAME
#167COMPOSITIONS AND METHODS RELATED TO NUCLEIC ACID ANTICOAGULANTS AND ANTIDOTES
#168CTLA-4 APTAMER CONJUGATES
#169APTAMER-PEPTIDE CONJUGATES
#170METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS
#171ANALYSIS METHOD
#172DEVELOPMENT AND APPLICATION OF POLYMER-COATED GOLD NANOPARTICLE-APTAMER NANOCONSTRUCT HAVING SENSITIVITY TO REACTIVE OXYGEN SPECIES
#173NOVEL THERAPEUTIC AGENT FOR SEPTICEMIA, AND A METHOD FOR SCREENING FOR SAME
#174RNA-APTAMER-SENSORS
#175COMPOSITIONS AND METHODS FOR MODULATING CANCER IMMUNE FITNESS
#176VIRAL PROTEIN SPECIFIC APTAMERS AND METHODS OF USE IN DIAGNOSTICS, THERAPEUTIC PURPOSES
#177OLIGONUCLEOTIDE-TETHERED NUCLEOTIDES
#178NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CLL AND OTHER CANCERS
#179IMMOLATIVE CELL-PENETRATING COMPLEXES FOR NUCLEIC ACID DELIVERY
#180MEDIUM-MOLECULAR-WEIGHT COMPOUND CONJUGATE FOR IMPROVING PHARMACOKINETIC PROFILE OF MEDIUM-MOLECULAR-WEIGHT COMPOUND AND METHOD OF PRODUCING THE SAME
#181AFFINITY REAGENT
#182COVALENT APTAMERS
#183ELECTROCHEMICAL, APTAMER-BASED POINT-OF-CARE CEREBROSPINAL FLUID DETECTION
#184HOMOLOGOUS RECOMBINATION VIA TRANSCRIPTIONAL ACTIVATION
#185FATTY ACID CONJUGATES OF NUCLEIC ACIDS
#186THERAPEUTIC OLIGONUCLEOTIDES
#187RNA APTAMERS SPECIFIC FOR A-SYNUCLEIN PROTEIN FIBER CONFORMERS
#188SIRNA CONSTRUCTS FOR INHIBITING GENE EXPRESSION IN TARGETED CANCER CELLS
#189MULTITARGETING RNA COMPOSITIONS
#190Aptamer for specifically recognizing soluble ST2 protein and application of the same
#191Compositions for Inhibiting Growth of Targeted Cells
#192Multitargeting RNA Immunotherapy Compositions
#193TM4SF19 INHIBITOR AND USES THEREOF
#194MODULATION OF GENE EXPRESSION FOR DISEASE TREATMENT
#195NON-IMMUNOGENIC POEGMA-APTAMER CONJUGATES
#196BISPECIFIC APTAMER FOR TREATING CANCER
#197APTAMER-TYPE MULTI-WARHEAD COVALENT DRUG
#198DNA APTAMER SPECIFICALLY BINDING TO METHYLATED DNA FRAGMENT AND SELECTION METHOD AND USE THEREOF
#199Nucleic Acid Compounds That Bind Coronavirus Proteins
#200METHODS AND COMPOSITIONS FOR PROTEIN AND PEPTIDE SEQUENCING
#201Aptamers For Personal Health Care Applications
#202METHODS AND COMPOSITIONS COMPRISING MHC CLASS I PEPTIDES
#203NUCLEIC ACID MOLECULE CONJUGATE HAVING PROLONGED IN VIVO HALF-LIFE
#204APTAMERS FOR USE IN THE TREATMENT OF CORONAVIRIDAE INFECTIONS
#205DEFINED MULTI-CONJUGATES OLIGONUCLEOTIDES
#206REGULATION OF GENE EXPRESSION THROUGH APTAMER-MODULATED POLYADENYLATION
#207COMPOUNDS AND METHODS FOR REDUCING PLN EXPRESSION
#208Checkpoint Aptamers as Therapeutics for Cancer Treatment
#209DEOXYRIBONUCLEOSIDE OR DEOXYRIBONUCLEOTIDE HAVING NOVEL ARTIFICIAL BASE APPLICABLE TO SCREENING FOR DNA APTAMER, AND NUCLEIC ACID CONTAINING THE SAME
#210HOMOLOGOUS RECOMBINATION VIA TRANSCRIPTIONAL ACTIVATION
#211DEVELOPMENT OF APTAMERS FOR NEUTRALIZING ANTIBODIES IN DEMYELINATING DISEASES
#212CANCER THERAPY
#213APTAMERS, CONTAINERS AND METHODS FOR CELL TRANSDUCTION
#214MOLECULES THAT BIND TO AND STABILIZE TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 (TREM2)
#215RIBOSWITCH MODULATED GENE THERAPY FOR RETINAL DISEASES
#216APTAMERS THAT SELECTIVELY BIND TO A SARS-COV-2 VIRUS NUCLEOCAPSID PROTEIN
#217Nucleolin-targeting aptamers and methods of using the same
#218OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF
#219IMMUNOADJUVANT-BASED HYDROGEL COMPOSITION AND USE THEREOF
#220ANTIDOTE-MEDIATED REVERSAL OF EXTRACELLULAR APTAMER STAINING
#221MULTIPLEX RNA TARGETING
#222THERAPEUTIC OLIGONUCLEOTIDES
#223ANTI-C5 AGENT FOR TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION (AMD) OR GEOGRAPHIC ATROPHY SECONDARY TO DRY AMD
#224TM4SF19 INHIBITOR AND USES THEREOF
#225MODULATION OF GENE EXPRESSION FOR DISEASE TREATMENT
#226NON-IMMUNOGENIC POEGMA-APTAMER CONJUGATES
#227Hybridization Chain Reaction Methods for In Situ Molecular Detection
#228DNA APTAMERS AND COMPOSITIONS TARGETING ALPHA-SYNUCLEIN AND METHODS OF MAKING AND USING SAME
#229Peptides and combination of peptides for use in immunotherapy against non-small cell lung cancer and other cancers
#230FUNCTIONAL LIGANDS
#231ENGINEERED EXTRACELLULAR VESICLES AND THEIR USES
#232NOVEL RNA APTAMER INTERVENES ESTROGEN RECEPTOR INTERACTION WITH COACTIVATOR MED1 TO OVERCOME BREAST CANCER METASTASIS
#233MODULATING BONE MORPHOGENIC PROTEIN (BMP) SIGNALING IN THE TREATMENT OF ALZHEIMER'S DISEASE
#234OLIGONUCLEOTIDE-TETHERED NUCLEOTIDES
#235PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND OTHER CANCERS
#236DUAL CHECKPOINT INHIBITOR APTAMER BASED THERAPEUTICS
#237DEAD GUIDES FOR CRISPR TRANSCRIPTION FACTORS
#238IMMUNOTHERAPY WITH B*07 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS
#239PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS
#240METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS
#241RNA MOLECULES, METHODS OF PRODUCING CIRCULAR RNA, AND TREATMENT METHODS
#242APTAMERS AND USE OF THE APTAMERS IN THE DIAGNOSIS AND TREATMENT OF A SARS-COV-2 INFECTION
#243DUAL-SPECIFIC APTAMER TRIGGERING CELL-MEDIATED CYTOTOXICITY TO LYSE HER2-POSITIVE CANCER CELLS
#244DUAL-SPECIFIC APTAMER TRIGGERING CELL-MEDIATED CYTOTOXICITY TO LYSE HER2-POSITIVE CANCER CELLS
#245APTAMER-siRNA FUSIONS
#246COMPOSITIONS AND METHODS TO TREAT CANCER
#247Bispecific Aptamer Compositions for the Treatment of Retinal Disorders
#248DNA APTAMERS FOR THE DETECTION OF MONOMERIC CRP
#249SHELF-STABLE, READY-TO-USE, ELECTROCHEMICAL APTAMER SENSORS
#250COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING VIRAL INFECTIONS
#251NEUTRALIZABLE COVALENT DRUG
#252DUAL-SPECIFIC APTAMER TRIGGERING CELL-MEDIATED CYTOTOXICITY TO LYSE HER2-POSITIVE CANCER CELLS
#253DNA-COLLAGEN COMPLEXES AND MAGNETOELECTRIC JANUS MATERIALS FOR BIOMEDICAL APPLICATIONS
#254DEOXYRIBONUCLEIC ACID-BASED BIOSENSOR AND ASSOCIATED METHODS
#255Universal platform to enhance CRISPR-based gene editing for in vivo therapies
#256REGULATION OF GENE EXPRESSION BY APTAMER-MODULATED RNASE P CLEAVAGE
#257COMPOSITIONS AND METHODS FOR TREATMENT OF BLEEDING DISORDERS
#258SARS-CoV-2 SPIKE GLYCOPROTEIN-BINDING NUCLEIC ACID MOLECULE, SARS-CoV-2 DETECTION SENSOR, SARS-CoV-2 DETECTION REAGENT, SARS-CoV-2 DETECTION METHOD, AND SARS-CoV-2 VIRUS DEACTIVATOR
#259METHODS OF CELL CULTURE FOR ADOPTIVE CELL THERAPY
#260NUCLEIC ACID NANOSTRUCTURES FOR DELIVERY OF NUCLEIC ACID SEQUENCES TO CELLS
#261APTAMER METHOD
#262METHODS OF CELL CULTURE FOR ADOPTIVE CELL THERAPY
#263APTAMER ASSEMBLIES FOR PROTEIN CROSSLINKING
#264NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#265METHOD FOR PREPARING A DNA NETWORK WITH CONTROLLED CRYSTAL STRUCTURE AND A METHOD FOR INJECTING DRUGS USING THE DNA NETWORK
#266COMPOSITIONS, SYSTEMS, AND METHODS FOR ORTHOGONAL GENOME ENGINEERING IN PLANTS
#267PROCESS FOR SELECTION OF APTAMERS, RIBOSWITCHES AND DESOXYRIBOSWITCHES
#268Methods for treating or preventing ophthalmological conditions
#269METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL CONDITIONS
#270SELF-TARGETING EXPRESSION VECTOR
#271METHODS FOR DE-CLOAKING CANCER FROM THE IMMUNE SYSTEM THROUGH DOWNREGULATION OF CANCER-PRODUCED PREGNANCY SPECIFIC GLYCOPROTEIN
#272PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS
#273APTAMER TEMPLATE AND METHOD FOR PREPARING APTAMER BY USING SAME
#274APTAMERS FOR PERSONAL HEALTH CARE APPLICATIONS
#275COMPOSITIONS COMPRISING LINEAR POLYRIBONUCLEOTIDES FOR PROTEIN MODULATION AND USES THEREOF
#276METHODS OF TREATMENT OF INFLAMMATORY BOWEL DISEASES
#277NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#278NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#279APTAMER SENSORS WITH CONTINUOUS SOLUTE PASSIVATION
#280CELL-FREE BIOSENSORS WITH DNA STRAND DISPLACEMENT CIRCUITS AND POLYMERASE STRAND RECYCLING (PSR)
#281BUILDING DESIGNER RNA NANO-STRUCTURES FOR SYNTHETIC BIOLOGY APPLICATIONS
#282MATERIALS AND METHODS FOR THE DELIVERY OF THERAPEUTIC NUCLEIC ACIDS TO TISSUES
#283BIFUNCTIONAL MOLECULES AND METHODS OF USING THEREOF
#284IMMUNOTHERAPY WITH B*07 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS
#285Radioisotope and Aptamer Drug Combination to treat S. aureus and E. coli infections
#286THROMBUS IMAGING APTAMERS AND METHODS OF USING SAME
#287Targeting ligands for tau pathology
#288PORTABLE DETECTION OF SARS-COV-2 USING UNIMOLECULAR APTASENSORS
#289ANTI-CHYMASE APTAMER AND USE FOR SAME
#290FLUOROARABINO NUCLEIC ACID (FANA) APTAMERS THAT BIND SARS-2 RECEPTOR BINDING DOMAIN AND BLOCK BINDING TO THE ACE2 CELLULAR RECEPTOR
#291Oligonucleotides comprising modified nucleosides
#292APTAMERS FOR PERSONAL HEALTH CARE APPLICATIONS
#293NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR GENERATING SCAFFOLDS FOR THE USE AGAINST PANCREATIC CANCER AND OTHER CANCERS
#294NUCLEIC ACID-BINDING PHOTOPROBES AND USES THEREOF
#295LENTIVIRAL-FREE CYTOSOLIC DELIVERY OF PAYLOADS VIA APTAMERS
#296DNA aptamer, pharmaceutical composition comprising same, method for inhibiting catalytic ability of TXNDC5, and method for preventing or treating organ fibrosis
#297CONTINUOUS CORTISOL MONITORING SYSTEM WITH MICRONEEDLE ARRAY
#298Method for Detecting Alpha Fetoprotein Glycoforms by High Resolution Intact Mass Analysis
#299APTAMER BASED AFFINITY CAPTURE METHODS FOR THE SELECTIVE ENRICHMENT OF HUMAN IMMUNOGLOBULIN FC DOMAINS
#300DNA APTAMERS FOR EOSINOPHIL PEROXIDASE DETECTION